Abstract
This review summarizes various aspects of the inherited kidney disorder nephrogenic diabetes insipidus (NDI). The clinical manifestations of the disease are presented. The important role of the genetic localization of the NDI gene to the X-chromosome long arm, in region Xq28, for carrier detection and early (prenatal) diagnosis of the disorder is emphasized. Following an overview of the cellular physiology involved in the antidiuretic action of vasopressin, possible mechanisms in the pathogenesis of NDI are discussed. We hypothesize that NDI is most probably due to the absence or abnormality of the renal V2 receptor. This assumption is strengthened by recent findings in receptor studies, which indicate a general V2 receptor defect in NDI, and in experiments with somatic cell hybrid cell lines, which are consistent with a co-localization of the genes for NDI and for the V2 receptor in the Xq28 region. Finally, the efficacy of the combination amiloride-hydrochlorothiazide, compared with the indomethacin-hydrochlorothiazide regimen, in the treatment of NDI is presented and the advantages of the former combination are discussed.
Similar content being viewed by others
References
Forssman H (1945) On hereditary diabetes insipidus with special regard to a sex linked form. Acta Med Scand 159:3–196
Waring AJ, Kajdi L, Tappan V (1945) A congenital defect of water metabolism. Am J Dis Child 69:323–324
Williams RH, Henry C (1947) Nephrogenic diabetes insipidus: transmitted by females and appearing during infancy in males. Ann Intern Med 27:84–95
Holliday MA, Burstin C, Harrah J (1963) Evidence that the antidiuretic substance in the plasma of children with nephrogenic diabetes is antidiuretic hormone. Pediatrics 32:384–388
Luder J, Burnett D (1954) A congenital renal tubular defect. Arch Dis Child 29:44–47
Hillman DA, Neyzi O, Porter P, Cushman A, Talbot NB (1958) Renal (vasopressin-resistant) diabetes insipidus: definition of the effects of a homeostatic limitation in capacity to conserve water on the physical, intellectual and emotional development of a child. Pediatrics 21:430–435
Vest M, Talbot NB, Crawford JD (1963) Hypocaloric dwarfism and hydronephrosis in diabetes insipidus. Am J Dis Child 105:175–181
Macaulay D, Watson M (1967) Hypernatraemia in infants as a cause of brain damage. Arch Dis Child 42:485–491
Kanzaki S, Omura T, Miyake M, Enomoto S, Miyata I, Ishimitsu H (1985) Intracranial calcification in nephrogenic diabetes insipidus. JAMA 254:3349–3350
Forssman H (1955) Is hereditary diabetes insipidus of nephrogenic type associated with mental deficiency? Acta Psychiatr Neurol Scand 30:577–587
Ten Bensel RW, Peters ER (1970) Progressive hydronephrosis, hydroureter, and dilatation of the bladder in siblings with congenital nephrogenic diabetes insipidus. J Pediatr 77:439–443
Gorden P, Robertson GL, Seegmuller JE (1971) Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult. N Engl J Med 284:1057–1060
Bichet DG, Arthus M-F, Lonergan M (1991) Platelet vasopressin receptors in patients with congenital nephrogenic diabetes insipidus. Kidney Int 39:693–699
Usberti M, Dechaux M, Guillot M, Seligmann R, Pavlovitch H, Loriat C, Sachs C, Broyer M (1980) Renal prostaglandin E2 in nephrogenic diabetes insipidus: effect of inhibition of prostaglandin synthesis by indomethacin. J Pediatr 97:476–478
Monnens L, Jonkman A, Thomas C (1984) Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci 66:709–715
Walker NF, Rance CP (1954) Inheritance of nephrogenic diabetes insipidus. Am J Hum Genet 6:354–358
Carter C, Simpkiss M (1956) The “carrier” state in nephrogenic diabetes insipidus. Lancet II:1069–1073
Bode HH, Crawford JD (1969) Nephrogenic diabetes insipidus in North America — The Hopewell hypothesis. N Engl J Med 280: 750–754
Robinson MG, Kaplan SA (1960) Inheritance of vasopressin-resistant (‘nephrogenic’) diabetes insipidus. Am J Dis Child 99: 164–174
Schreiner RL, Skafish PR, Anand SK, Northway JD (1978) Congenital nephrogenic diabetes insipidus in a baby girl. Arch Dis Child 53: 906–915
Knoers N, Heyden H van der, Oost BA van, Monnens L, Willems J, Ropers HH (1987) Tight linkage between nephrogenic diabetes insipidus and DXS52. Cytogenet Cell Genet 46:640
Knoers N, Heyden H van der, Oost BA van, Monnens L, Willems J, Ropers HH (1988) Linkage of X-linked nephrogenic diabetes insipidus with DXS52, a polymorphic DNA marker. Nephron 50: 187–190
Knoers N, Heyden H van der, Oost BA van, Ropers HH, Monnens L, Willems J (1988) Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X-chromosome. Hum Genet 80:31–38
Knoers N, Heyden H van der, Oost BA van, Monnens L, Willems J, Ropers HH (1988) Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus. Genomics 4:434–437
Langley JM, Balfe JW, Selander T, Ray PN, Clarke JTR (1991) Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet 38:90–94
Michell RH, Kirk CJ, Billah MM (1979) Hormonal stimulation of phosphatidylinositol breakdown, with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans 7:861–865
Abramow M, Beauwens R, Cogan E (1987) Cellular events in vasopressin action. Kidney Int 32:56–66
Brown D (1989) Membrane recycling and epithelial cell function. Am J Physiol 256:F1-F12
Harris HW, Strange K, Zeidel ML (1991) Current understanding of the cellular biology and molecular structure of the antidiuretic hormone-stimulated water transport pathway. J Clin Invest 88:1–8
Kachadorian WA, Ellis SJ, Muller J (1979) Possible roles for microtubules and microfilaments in ADH action on toad urinary bladder. Am J Physiol 236:F14-F20
Dillingham MA, Dixon BS, Anderson RJ (1987) Calcium modulates vasopressin effect in rabbit cortical collecting tubule. Am J Physiol 252:F115-F121
Taylor A, Eich E, Pearl M, Brem AS, Peeper EQ (1987) Cytosolic calcium and the action of vasopressin in toad urinary bladder. Am J Physiol 252:F1028-F1041
Dillingham MA, Anderson RJ (1986) Inhibition of vasopressin action by atrial natriuretic factor. Science 231:1572–1573
Nonoguchi H, Sands JM, Knepper MA (1988) Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest 82:1383–1390
Lochrie MA, Simon MI (1988) G-protein multiplicity in eukaryotic signal transduction systems. Biochemistry 27:4957–4965
Spiegel AM, Levine MA, Aurbach GD, Downs RW, Marx SJ, Lasker RD, Moses AM, Breslau NA (1982) Deficiency of hormone-receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism. Am J Physiol 243:E37-E42
Levine MA, Downs RW, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74:545–556
Naik DV, Valtin H (1969) Hereditary vasopressin-resistant urinary concentration defects in mice. Am J Physiol 217:1183–1190
Jackson BA, Edwards RM, Valtin H, Dousa TP (1980) Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus. J Clin Invest 66:110–122
Homma S, Gapstur SM, Coffey A, Dousa TP (1991) Role of the cAMP-phosphodiesterase isoenzymes in pathogenesis of murine nephrogenic diabetes insipidus. Am J Physiol 261:F345-F353
Beavo JA (1988) Multiple isoenzymes of cyclic nucleotide phosphodiesterase. Adv Second Messenger Phosphoprotein Res 22: 1–38
Krebs EG (1989) Role of the cyclic AMP-dependent protein kinase in signal transduction. JAMA 262:1815–1818
Lee DC, Carmichael DF, Krebs EG, McKnight GS (1983) Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase. Proc Natl Acad Sci USA 80:3608–3612
Jahnsen T, Hedin L, Kidd VJ, Beattie WG, Lohmann SM, Walter U, Durica J, Schulz TZ, Schiltz E, Browner M, Lawrence CB, Goldman D, Ratoosh SL, Richards JS (1986) Molecular cloning, cDNA structure, and regulation of the regulatory subunit of type II cAMP-dependent protein kinase from rat ovarian granulosa cells. J Biol Chem 261:12352–12361
Brommer EJP, Brummelen P van, Derkx FHM (1984) Desmopressin and hypotension. Ann Intern Med 103:962
Cash JD, Gader AMA, Da Costa J (1974) The release of plasminogen activator and FVIII by LVP, AVP, DDAVP, ATIII, and OT in man. Br J Haematol 27:363–364
Mannuci PM, Aberg M, Nilsson IM, Robertson B (1975) Mechanism of plasminogen activator and FVIII increase after vasoactive drugs. Br J Haematol 30:81–93
Kobrinski NL, Doyle JJ, Israel EDS, Winter JSD, Cheang MS, Walker RD, Bishop A (1985) Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet I:1293–1294
Bichet DG, Razi M, Lonergan M, Arthus M-F, Papukna V, Kortas C, Barjon J-N (1988) Hemodynamic and coagulation responses to 1-desamino [8-d-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318:881–887
Knoers N, Brommer EJP, Willems H, Oost BA van, Monnens LAH (1990) Fibrinolytic responses to 1-desamino-8-d-arginine vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron 54:322–326
Knoers N, Monnens LAH (1991) A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr 150:370–373
Brenner B, Seligsohn U, Hochberg Z (1988) Normal response of factor VIII and von Willebrand factor to 1-deamino-8-d-arginine vasopressin in nephrogenic diabetes insipidus. J Clin Endocrinol Metab 67:191–193
Moses AM, Miller JL, Levine MA (1988) Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 66:1259–1264
Ohzeki T, Sanuguchi M, Tsunei M, Shinzawa T, Hanaki K, Shiraki K (1988) Coagulation factor responsiveness in nephrogenic diabetes insipidus. J Pediatr 113:790
Anderson JG, Notmann DD, Springer J (1979) Studies in nephrogenic diabetes insipidus. Clin Res 27:477A
Knoers N, Janssens PMW, Goertz J, Monnens LAH (1991) Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus. Eur J Pediatr (in press)
Jans DA, Oost BA van, Ropers HH, Fahrenholz F (1990) Derivatives of somatic cell hybrids which carry the gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem 265:15379–15386
Rasher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW (1987) Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol 1:485–490
Libber S, Harrison H, Spector D (1986) Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108:305–311
Alon U, Chan JCM (1985) Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 5:9–13
Knoers N, Monnens LAH (1990) Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr 117:499–502
Dyckner T, Wester P-O, Widman L (1988) Amiloride prevents thiazide-induced intracellular potassium and magnesium losses. Acta Med Scand 224:25–30
Wilson DR, Honrath U, Sonnenberg H (1988) Interaction of amiloride and hydrochlorothiazide with atrial natriuretic factor in the medullary collecting duct. Can J Physiol Pharmacol 66:648–654
Costanzo LS (1985) Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol 248: F527-F535
Ellison DH, Velazquez H, Wright FS (1987) Thiazide-sensitive sodium-chloride contransport in early distal tubule. Am J Physiol 253: F546-F554
Sonnenberg H, Honrath U, Wilson DR (1987) Effects of amiloride in the medullary collecting duct of rat. Kidney Int 31:1121–1125
Velazquez H, Wright FS (1986) Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule. Am J Physiol 250: F1013-F1023
Early LE, Orloff J (1962) The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant nephrogenic diabetes insipidus. J Clin Invest 52: 2418–2427
Ramos G, Rivera A, Pena JC, Dies F (1967) Mechanism of the antidiuretic effect of saluretic drugs. Studies in patients with diabetes insipidus. Clin Pharmacol Ther 8:557–565
Ambrosiono E, Tartagni F, Nacarella F, Magnani B, Ferriri C (1980) Comparison of the effects of amiloride and tiamterene used alone or combined with hydrochlorothiazide. Drug Exp Clin Res 6: 709–712
Ruddle FH (1984) The William Allan memorial award address: reverse genetics and beyond. Am J Hum Genet 36:944–953
Orkin SH (1986) Reverse genetics and human disease. Cell 47: 845–850
Ropers HH (1987) Use of DNA probes for diagnosis and prevention of inherited disorders. Eur J Clin Invest 17:475–487
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Knoers, N., Monnens, L.A.H. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment. Pediatr Nephrol 6, 476–482 (1992). https://doi.org/10.1007/BF00874020
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00874020